Exploiting synthetic lethal interactions for targeted cancer therapy

Author(s)
Reinhardt, H. Christian; Jiang, Hai; Hemann, Michael; Yaffe, Michael B
Thumbnail
DownloadHemann_Exploiting synthetic.pdf (427.9Kb)
OPEN_ACCESS_POLICY
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike 3.0 http://creativecommons.org/licenses/by-nc-sa/3.0/
Metadata
Show full item record
Abstract
Emerging data suggests that synthetic lethal interactions between mutated oncogenes/tumor suppressor genes and molecules involved in DNA damage signaling and repair can be therapeutically exploited to preferentially kill tumor cells. In this review, we discuss the concept of synthetic lethality, and describe several recent examples in which this concept was successfully implemented to target tumor cells in culture, in mouse models, and in human cancer patients.
Description
March 15, 2011
Date issued
2009-10
URI
http://hdl.handle.net/1721.1/73619
Department
Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Biology; Koch Institute for Integrative Cancer Research at MIT
Journal
Cell Cycle
Publisher
Landes Bioscience
Citation
Reinhardt, H. Christian et al. “Exploiting Synthetic Lethal Interactions for Targeted Cancer Therapy.” Cell Cycle 8.19 (2009): 3112–3119.
Version: Author's final manuscript
ISSN
1538-4101
Collections